You are here: Home → Publications

Publications

by c0li0003 — last modified Feb 26, 2009 08:04 PM




1995 1996 1997 1998 1999 2000 2001 2002 2003 2004 2005 2006 2007 2008

1995

  1. Dunker DH, Stoddard MF, Prince CR, Williams TE. Potential for contamination of transesophageal echocardiographic scopes by radionuclides from patients undergoing nuclear imaging studies. Am Heart J 130:397-398, 1995.

  2. Stoddard MF, Dawkins PR, Prince CR, Longaker RA. Transesophageal echocardiographic guidance of cardioversion in patients with atrial fibrillation. Am Heart J 129:1204-1215, 1995.

  3. Hasnie AM, Stoddard MF, Gleason CB, Wagner SG, Longaker RA, Pierangeli S, Harris EN. Diastolic dysfunction is a feature of the antiphospholipid syndrome. Am Heart J 129:1009-1013, 1995.

  4. Stoddard MF, Prince CR, Dillon S, Longaker RA, Morris GT, Liddell NE. Exercise-induced mitral regurgitation is a predictor of morbid events in subjects with mitral valve prolapse. J Am Coll Cardiol 25:693-699, 1995.

  5. Stoddard MF, Dawkins PR, Prince CR, Ammash NM. Left atrial appendage thrombus is not uncommon in patients with acute atrial fibrillation and a recent embolic event: a transesophageal echocardiographic study. J Am Coll Cardiol 25:452-459, 1995.

  6. Stoddard MF, Prince CR, Morris GT. Coronary flow reserve assessment by dobutamine transesophageal Doppler echocardiography. J Am Coll Cardiol 25:325-332, 1995.

  7. Singer I, Goldsmith J, Maldonado C. Electrode surface area is an important variable for defibrillation. Pacing Clin Electrophysiol 18:233-236, 1995.

  8. Singer I, Goldsmith J, Maldonado C. Transseptal defibrillation is superior for transvenous defibrillation. Pacing Clin Electrophysiol. 18:229-232, 1995.

  9. Sekili S, Jeroudi MO, Tang XL, Zughaib M, Sun JZ, Bolli R. Effect of adenosine on myocardial "stunning" in the dog. Circ Res 76:82-94, 1995.

  10. Sun JZ, Tang XL, Knowlton AA, Park SW, Qiu Y, Bolli R. Late preconditioning against myocardial stunning. An endogenous protective mechanism that confers resistance to postischemic dysfunction 24 hours after brief ischemia in conscious pigs. J Clin Invest 95:388-403, 1995.

  11. Tang XL, McCay PB, Sun JZ, Hartley CJ, Schleman M, Bolli R. Inhibitory effect of a hydrophilic alpha-tocopherol analogue, MDL 74,405 on generation of free radices in stunned myocardium in dogs. Free Radic Res 22:293-302, 1995.

  12. Bolli R, Zughaib M, Li XY, Tang XL, Sun JZ, Triana JF, McCay PB. Recurrent ischemia in the canine heart causes recurrent bursts of free radical production that have a cumulative effect on contractile function. A pathophysiological basis for chronic myocardial "stunning". J Clin Invest. 96:1066-84,1995.

  13. Tang XL, Kaur H, Sun JZ, Qiu Y, Park SW, Schleman M, Halliwell B, Bolli R. Effect of the hydrophilic alpha-tocopherol analog MDL 74,405 on the detection of hydroxyl radicals in stunned myocardium in dogs. Am Heart J 130:940-948, 1995.

  14. Bolli R. Common methodological problems and artifacts associated with studies of myocardial stunning in vivo. Basic Res Cardiol 90:257-262, 1995.

Back to Top

1996

  1. Auchampach J, Caughey G, Linden J. A2B and not A3 adenosine receptors mediate degranulation of BR mastocyma cells. Drug Dev Res 32:147, 1996.

  2. Edmonds HL, Singer I. Quantitative electroencephalography for detection of cerebral ischemia. Anesthe Analg 82:1300, 1996.

  3. Sun JZ, Tang XL, Park SW, Qiu Y, Turrens JF, Bolli R. Evidence for an essential role of reactive oxygen species in the genesis of late preconditioning against myocardial stunning in conscious pigs. J Clin Invest. 97:562-76,1996. ( Full text in PDF file )

  4. Tang XL, Qiu Y, Park SW, Sun JZ, Kalya A, Bolli R. Time course of late preconditioning against myocardial stunning in conscious pigs. Circ Res. 79:424-34,1996. ( Full text in htm file )

  5. Park SW, Tang XL, Qiu Y, Sun JZ, Bolli R. Nisoldipine attenuates myocardial stunning induced by multiple coronary occlusions in conscious pigs and this effect is independent of changes in hemodynamics or coronary blood flow. J Mol Cell Cardiol . 28:655-66,1996. ( Full text in PDF file )

  6. Wallis G, Brackett D, Lerner M, Kotake Y, Bolli R, McCay PB. In vivo spin trapping of nitric oxide generated in the small intestine, liver, and kidney during the development of endotoxemia: a time-course study. Shock 6:274-278, 1996.

  7. Giordano F, Ping P, McKirnan D, Nozaki S, DeMaria S, Dillmann W, Mathieu-Costello O, Hammond HK. Intracoronary gene transfer of fibroblast gworth factor-5 increases blood flow and contractile function in an ischemic region of the heart. Nature 2:534-539, 1996.

  8. Stoddard MF, Wagner SG, Ikram S, Longaker RA, Prince CR. Effects of nifedipine and nitroglycerin on left ventricular systolic dysfunction and impaired diastolic filling after exercise-induced ischemia in humans. J Am Coll Cardiol 28:915-923, 1996.

  9. Stoddard MF, Hammon RT, Longaker RA. Doppler transesophageal echocardiographic determination of aortic valve area in adults with aortic stenosis. Am Heart J 132:337-342, 1996.

  10. Stoddard MF. Risk of thromboembolism in new onset or transient atrial fibrillation. Prog Cardiovasc Dis 39:69-80, 1996.

  11. Maldonado C, Talley JD, Mayfield-Stokes S, Leesar M, Shih A, Kalya A. Exogenous Fibronectin to Prevent Neointimal Hyperplasia after Balloon Angioplasty. J Invasive Cardio 8:107-112, 1996.

  12. Talley JD, Mauldin PD, Becker ER, Stikovac M, Leesar MA. Cost and therapeutic modification of intracoronary ultrasound-assisted coronary angioplasty. Am J Cardiol 77:1278-1282, 1996.

Back To Top

1997

  1. Auchampach JA, Rizvi A, Qiu Y, Tang XL, Maldonado C, Teschner S, Bolli R. Selective activation of A3 adenosine receptors with N6-(3- iodobenzyl)adenosine-5'-N-methyluronamide protects against myocardial stunning and infarction without hemodynamic changes in conscious rabbits. Circ Res. 80:800-9,1997.( Full text in htm file )

  2. Maldonado C, Qiu Y, Tang XL, Cohen MV, Auchampach J, Bolli R. Role of adenosine receptors in late preconditioning against myocardial stunning in conscious rabbits. Am J Physiol. 273:H1324-32,1997.

  3. Auchampach JA, Jin X, Wan TC, Caughey G, Linden J (1997). Canine mast cell adenosine receptors: Cloning and expression of the A3 adenosine receptor and evidence that degranulation is mediated by the A2B receptor. Mol Pharm 52: 846 – 860, 1997.

  4. Johnson MR, Naftel DC, Hobbs RE, Kobashigawa JA, Pitts DE, Levine TB, Tolman D, Bhat G, Kirklin KL. Bourge RC and the CTRD Group. The incremental risk of female gender in cardiac transplantation: A multi-institutional study of peripartum cardiomyopathy and pregnancy. J Heart Lung Transplant 16:801, 1997.

  5. Bhat G, Schroeder TJ. Clinical role of immunologic monitoring during OKT3 treatment. Transplantation Proceedings 29:15S-20S, 1997.

  6. Daoud J, Bhat G, Schroeder T. Are surveillance endomyocardial biopsies necessary during OKT3 induction therapy. Transplantation 64:368, 1997.

  7. French, BA: Present and future of gene therapy in cardiovascular disease. Cardiology in Review 5:129-140, 1997.

  8. Agah R, Frenkel PA, French BA, Michael LH, Overbeek PA, and Schneider MD: Gene recombination in post-mitotic cells: Targeted expression of Cre recombinase provokes cardiac-restricted, site-specific rearrangement in adult ventricular muscle in vivo. J Clin Invest 100:169-179, 1997.

  9. Leesar, MA, Ahmed M. Broadbent J, Bolli R. Adenosine preconditions human myocardium during PTCA. Circulation 95:2500-207, 1997

  10. Leesar MA, Stoddard M, Ahmed M, Broadbent J, Bolli R. Preconditioning of human myocardium with adenosine during coronary angioplasty. Circulation. 95:2500-7,1997.( Full text in htm file )

  11. Bolli R, Bhatti ZA, Tang XL, Qiu Y, Zhang Q, Guo Y, Jadoon AK. Evidence that late preconditioning against myocardial stunning in conscious rabbits is triggered by the generation of nitric oxide. Circ Res. 81:42-52,1997. ( Full text in htm file )

  12. Bolli R, Leesar MA. Letter to editor. J Am Coll Cardiol 1997; 29:456-470.

  13. Ping P, Zhang J, Qiu Y, Tang XL, Manchikalapudi S, Cao X, Bolli R. Ischemic preconditioning induces selective translocation of protein kinase C isoforms epsilon and eta in the heart of conscious rabbits without subcellular redistribution of total protein kinase C activity. Circ Res. 81:404-14,1997.  ( Full text in htm file )

  14. Ping P, Anzai T, Gao M, Hammond HK. Adenylylcyclase and G-protein receptor kinase expression during the development of pacing-induced heart failure in the pig. Am J Physiol 273:H707-H717, 1997.

  15. Singer I, Deam G, Payne V, Cicic A, Martin T. Clinical results with electrophysiologist-implanted cardioverter-defibrillators. Pacing Clin Electrophysiol 20:189-193, 1997.

  16. Leesar MA, Stoddard MF, Ahmed M. Broadbent J, Bolli R. Preconditioning of human myocardium with adenosine during coronary angioplasty. Circulation 95:2500-2507, 1997.

  17. Klein AL, et al. For the ACUTE Investigators. Cardioversion Guided Transesophageal Echocardiography: The ACUTE pilot study. A randomized, Controlled Trial. Ann Int Med 126:200-209, 1997.

  18. Ouseph R, Stoddard MF, Lederer ED. Patient Forament Ovale Presenting as Refractory Hypoxemiz after Cardiac Transplantation. J Am Soc Echocardiography 10:973-976, 1997.

  19. Leesar MA, Bhatti Z, Maden R, Xenopolous N, Bolli R. Adenosine preconditions human myocardium against metabolic effects of ischemia during PTCA. J Am Coll Cardiol 29:316, 1997.

  20. Bolli R, Manchikalapudi S, Tang XL, Takano H, Qiu Y, Guo Y, Zhang Q, Jadoon AK. The protective effect of late preconditioning against myocardial stunning in conscious rabbits is mediated by nitric oxide synthase. Evidence that nitric oxide acts both as a trigger and as a mediator of the late phase of ischemic preconditioning. Circ Res.  81:1094-107, 1997.( Full text in htm file )

  21. Qiu Y, Rizvi A, Tang XL, Manchikalapudi S, Takano H, Jadoon AK, Wu WJ, Bolli R. Nitric oxide triggers late preconditioning against myocardial infarction in conscious rabbits. Am J Physiol . 273:H2931-6,1997. ( Full text in PDF file )

  22. Qiu Y, Tang XL, Park SW, Sun JZ, Kalya A, Bolli R. The early and late phases of ischemic preconditioning: a comparative analysis of their effects on infarct size, myocardial stunning, and arrhythmias in conscious pigs undergoing a 40-minute coronary occlusion. Circ Res. 80:730-42,1997.( Full text in htm file )

  23. Tang XL, Qiu Y, Turrens JF, Sun JZ, Bolli R. Late preconditioning against stunning is not mediated by increased antioxidant defenses in conscious pigs. Am J Physiol . 273:H1651-7,1997.( Full text in PDF file )

Back To Top

1998

  1. Auchampach JA, Maruyama M, Cavero I, Gross GJ. Effect of the platelet-activating factor antagonist RP 59227 on myocardial ischemia/reperfusion injury and neutrophil activation. Bas Res Cardiol 93:361-371, 1998.

  2. Li Q, Murphree SS, Willer SS, Bolli R, French BA. Gene therapy with bilirubin-UDP-glucuronosyltransferase in the Gunn rat model of Crigler-Najjar syndrome type 1 [see comments]. Hum Gene Ther. 9:497-505,1998.

  3. Bhat G, Schroeder TJ, Balakrishnan K: Can anti-HLA Antibody Analysis Postcardiac Transplantation predict acute allograft rejection and survival? Transplantation Proceedings 30:1154-1157, 1998.

  4. Baklanov DV, Ogurtsova OV, Masden RR: Restenosis After Successful angioplasty in total Occlusions of Coronary Arteries, Kardiologiya 38:10-12, 1998.

  5. Guo Y, Wu WJ, Qiu Y, Tang XL, Yang Z, Bolli R. Demonstration of an early and a late phase of ischemic preconditioning in mice. Am J Physiol. 275:H1375-87,1998. ( Full text in PDF file )

  6. Lenihan DJ, Rosenbaum AF, Burwinkel P, Tseng C, Bhat G, Wagoner L, Walsh RA, Gerson MC: Prediction of human transplant arteriopathy and coronary events using lung/heart count ratios during intravenous dipyridamole thallium-201 imaging. Am Heart J 137:942-948, 1998.

  7. Li Q, Bolli R, Qiu Y, Tang XL, Murphree SS, French BA. Gene therapy with extracellular superoxide dismutase attenuates myocardial stunning in conscious rabbits. Circulation . 98:1438-48,1998. ( Full text in PDF file )

  8. Linden J, Auchampach JA, Jin X, Figler RA. The structure and function of A1 and A2B adenosine receptors. Life Sciences 62:1519-1524, 1998.

  9. Marcassa C, Galli M, Bolli R, Temporelli PL, Campini R, Giannuzzi P. Heterogeneous fate of perfusion and contraction after anterior wall acute myocardial infarction and effects on left ventricular remodeling. Am J Cardiol 82:1457-1462, 1998.

  10. Bolli R, Leesar MA., Ahmed M. Stoddard M, Broadbent J. Adenosine-induced preconditioning of human myocardium. Circulation 98:824-825, 1998.

  11. Leesar MA (The Pursuit Trial Investigators). Inhibition of platelet glycoprotein IIb/IIIa with eptifibatide in patients with acute coronary syndromes. N Engl. J Med 339: 436-443, 1998.

  12. Qiu Y, Ping P, Tang XL, Manchikalapudi S, Rizvi A, Zhang J, Takano H, Wu WJ, Teschner S, Bolli R. Direct evidence that protein kinase C plays an essential role in the development of late preconditioning against myocardial stunning in conscious rabbits and that epsilon is the isoform involved. J Clin Invest. 101:2182-98,1998. ( Full text in PDF file )

  13. Ping P, Gao M, Post S, Insel PA, Tang R, Hammond HK. Increased expression of adenylylcyclase type VI proportionately increases B-adrenergic receptor-stimulated camp in neonatal rat cardiac myocytes. PNAS 95:1038-1043, 1998.

  14. Hammond HK, Ping P, Insel PA. Cardiac G-protein receptor kinase activity: effect of a beta-adrenergic receptor antagonist. Adv Pharmacol 42:507-510, 1998.

  15. Shawl FA, Domanski MJ, Kaul UP, Dougherty KG, Hoff SB, Cornell SL. Rigali G and Shahab ST. Procedural results and early clinical outcome of percutaneous transluminal myocardial revascularization. Am J Cardiol 83:498-501, 1998.

  16. Singer I, Dawn B, Edmonds HL Jr., Strickland J. Syncope is predicted by neuromonitoring in patients with ICDs. Pacing and Clinical Electrophysiology 22: 216 - 222, 1998.

  17. Soble, JS, Yurow G, Brar R, Stamos T, Neumann A, Garcia M, Stoddard MF, Cherian PK, Bhamb B, Thomas JD. Comparison of MPEG digital video with super VHS tape for diagnostic echocardio-graphic readings. J Am Soc Echo 11:819-825, 1998.

  18. Takano H, Manchikalapudi S, Tang XL, Qiu Y, Rizvi A, Jadoon AK, Zhang Q, Bolli R. Nitric oxide synthase is the mediator of late preconditioning against myocardial infarction in conscious rabbits. Circulation. 98:441-9,1998. ( Full text in PDF file )

  19. Takano H, Tang XL, Qiu Y, Guo Y, French BA, Bolli R. Nitric oxide donors induce late preconditioning against myocardial stunning and infarction in conscious rabbits via an antioxidant- sensitive mechanism. Circ Res. 83:73-84,1998. ( Full text in PDF file )

  20. Leesar MA, Matharu R, Xenopolous N, Pruit J, Stoddar M, Bolli R. Preconditioning of human myocardium with Bradykinin during PTCA. J Am Coll Cardiol 31:394, 1998.

  21. Xenopolous N, Leesar MA, Bolli R. Morphine mimics ischemic preconditioning in human myocardium during PTCA. J Am Coll Cardiol 31:65, 1998.

  22. Stoddard MF, Hasni AMA, Leesar MA, Bolli R. Adenosine preconditions against ischemia-induced systolic and diastolic dysfunction during percutaneous coronary angioplasty. J Am Coll Cardiol 31:459, 1998.

  23. Bolli R, Dawn B, Tang X-L, Qiu Y, Ping P, Xuan Y-T, Jones WK, Takano H, Guo Y, Zhang J. The nitric oxide hypothesis of late preconditioning. Basic Res Cardiol 93:325-338, 1998. ( Full text in PDF file )

Back To Top

1999

  1. Banerjee S, Tang XL, Qiu Y, Takano H, Manchikalapudi S, Dawn B, Bolli R.  Nitroglycerin induces late preconditioning against myocardial stunning via a protein kinase dependent pathway. Am J Physiol  277:H2488-H2494, 1999.( Full text in PDF file )

  2. Bhatnagar, A., Srivastava, S., Wang, L., Chandra, A., Ansari, N.H., Srivastava, S.K. Cardiac metabolism of enals. Adv. Exp. Med. Biol 463:223-229, 1999.

  3. Dawn B, Xuan YT, Qiu Y, Takano H, Tang XL, Ping P, Banerjee S, Hill M, Bolli R. Bifunctional role of protein tyrosine kinases in late preconditioning against myocardial stunning in conscious rabbits [see comments].  Circ Res.  85:1154-1163, 1999. ( Full text in PDF file )

  4. Guo Y, Jones WK, Xuan YT, Tang XL, Bao W, Wu WJ, Han H, Laubach VE, Ping P, Yang Z, Qiu Y, Bolli R.  The late phase of ischemic preconditioning is abrogated by targeted disruption of the inducible NO synthase gene. Proc Natl Acad Sci USA   96:11507-11512, 1999.  ( Full text in PDF file )

  5. Jones WK, Flaherty MP, Tang XL, Takano H, Qiu Y, Banerjee S, Smith T, Bolli R.  Ischemic preconditioning increases iNOS transcript levels in conscious rabbits via a nitric oxide-dependent mechanism [In Process Citation]. J Mol Cell Cardiol 31:1469-1481, 1999. ( Full text in PDF file )

  6. Jordan JE, Thourani VH, Auchampach JA, Robinson JA, Wang NP, Vinten-Johansen J. A3 adenosine receptor activation attenuates neutrophil function and neutrophil-mediated reperfusion injury. Am J Physiol 277:H1895-H1905, 1999.

  7. Leesar MA, Stoddard MF, Manchikalapudi S, Bolli R. Bradykinin-induced preconditioning in patients undergoing coronary angioplasty.  J Am Coll Cardiol.   34:639-650, 1999. ( Full text in PDF file )

  8. Mahaffey KW, Puma JA, Barbagelata NA, DiCarli MF, Leesar MA, Browne KF, Eisenberg PR, Bolli R, Casas AC, Molina-Viamonte V, Orlandi C, Blevins R, Gibbons RJ, Califf RM, Granger CB. Adenosine as an adjunct to thrombolytic therapy for acute myocardial infarction: results of a multicenter, randomized, placebo-controlled trial: the Acute Myocardial Infarction STudy of ADenosine (AMISTAD) trial.  J Am Coll Cardiol.    34:1711-1720, 1999. ( Full text in PDF file )

  9. Murray RD, Shah A, Jasper SE, Goodman A, Deitcher SR, Katz WE, Malouf JF, Stoddard MF, Grimm RA, Klein AL. Transesophageal echocardiography guided enoxaparin antithrombotic strategy for cardioversion of atrial fibrillation: the ACUTE II pilot study. Am Heart J 139:1-7, 1999.

  10. Petrash J.M., Harter TM, Srivastava S., Chandra A., Bhatnagar A., Srivastava, SK. Structure-function studies of FR-1: A growth factor-inducible aldo-keto reductase. Adv Exp Med Biol 463: 435-443, 1999.

  11. Auchampach JA, Bolli R. Adenosine receptor subtypes in the heart: therapeutic opportunities and challenges [editorial; comment].  Am J Physiol    276:H1113-H1116, 1999.( Full text in PDF file )

  12. Ping P, Takano H, Zhang J, Tang XL, Qiu Y, Li RC, Banerjee S, Dawn B, Balafonova Z, Bolli R. Isoform-selective activation of protein kinase C by nitric oxide in the heart of conscious rabbits: a signaling mechanism for both nitric oxide- induced and ischemia-induced preconditioning. Circ Res. 84:587-604,1999.  ( Full text in PDF file )

  13. Xuan YT, Tang XL, Banerjee S, Takano H, Li RC, Han H, Qiu Y, Li JJ, Bolli R. Nuclear factor-kappaB plays an essential role in the late phase of ischemic preconditioning in conscious rabbits. Circ Res. 84:1095-109,1999. ( Full text in PDF file )

  14. Ping P, Zhang J, Cao X, Li RC, Kong D, Tang XL, Qiu Y, Manchikalapudi S, Auchampach JA, Black RG, Bolli R.  PKC-dependent activation of p44/p42 MAPKs during myocardial ischemia- reperfusion in conscious rabbits. Am J Physiol. 276:H1468-H1481, 1999.( Full text in PDF file )

  15. Ping P, Zhang J, Huang S, Cao X, Tang XL, Li RC, Zheng YT, Qiu Y, Clerk A, Sugden P, Han J, Bolli R. PKC-dependent activation of p46/p54 JNKs during ischemic preconditioning in conscious rabbits.  Am J Physiol    277:H1771-H1785, 1999. ( Full text in PDF file )

  16. Ping P, Zhang J, Zheng YT, Li RC, Dawn B, Tang XL, Takano H, Balafanova Z, Bolli R. Demonstration of selective protein kinase C-dependent activation of Src and Lck tyrosine kinases during ischemic preconditioning in conscious rabbits. Circ Res.    85:542-550, 1999. ( Full text in PDF file )

  17. Rizvi A, Tang XL, Qiu Y, Xuan YT, Takano H, Jadoon AK, Bolli R.  Increased protein synthesis is necessary for development of late preconditioning against myocardial stunning. Am J Physiol 277:H874-H884, 1999. ( Full text in PDF file )

  18. Shinmura K, Tang XL, Takano H, Hill M, Bolli R.  Nitric oxide donors attenuate myocardial stunning in conscious rabbits. Am J Physiol 277:H2495-H2503, 1999. ( Full text in PDF file )

  19. Srivastava, S.K., Chandra, A., Srivastava, S., Petrash, J.M., Bhatnagar, A., Regulation of aldose reductase by aldehydes and nitric oxide. Adv Exp Med Biol 463:501-507, 1999.

  20. Srivastava, S., Watowich, S.J., Petrash, J.M., Srivastava, S.K. and Bhatnagar, A. Structural and kinetic determinants of aldehyde reduction catalyzed by aldose reductase. Biochemistry 38:42-54, 1999.

  21. Stoddard MF. Risk of thromboembolism in acute atrial fibrillation or atrial flutter. Echocardiography J 17:393-405, 1999.

  22. Takeishi Y, Ping P, Bolli R, Kirkpatrick DL, Hoit BD, Walsh RA. Transgenic overexpression of constitutively active protein kinase C  causes concentric cardiac hypertrophy. Circ Res 86:1218-1223, 1999.

  23. Wang Y, Newton DC, Robb GB, Kau CL, Miller TL, Cheung AH, Hall AV, VanDamme S, Wilcox JN, Marsden PA. RNA diversity has profound effects on the translation of neuronal nitric oxide synthase. Proc Nat Acad Sci USA 96:12150-12155, 1999.

  24. Bolli R, Marban E. Molecular and cellular mechanisms of myocardial stunning.  Physiol Rev.    79:609-634, 1999.  ( Full text in PDF file )

Back To Top

2000

  1. Deng, D., Rokosh DG, Simpson PC. Autonomous and growth factor-induced hypertrophy in cultured neonatal mouse cardiac mycoytes: Comparison with rat. Circ. Res 87:781-788, 2000.

  2. Dixit BL, Balendiran GK, Watowich SJ, Srivastava S, Ramana KV, Petrash JM, Bhatnagar A, Srivastava SK. Kinetic and structural characterization of the glutathione binding site of aldose reductase. J Biol. Chem 275:21587-21595, 2000.

  3. Guo Y, Bao W, Wu WJ, Shinmura K, Tang XL, Bolli R. Evidence for an essential role of cyclooxygenase-2 as a mediator of the late phase of ischemic preconditioning in mice.  Basic Res Cardiol.   95:479-484., 2000. ( Full text in PDF file )

  4. Kim YI, Shirwadkar S, Choi SW, Puchyr M, Wang Y, Mason JB. Effects of dietary folate on DNA strand breaks within mutation-prone exons of the p53 gene in rat colon. Gastroenterology 119:151-161, 2000.

  5. Li RC, Ping P, Zhang J, Wead WB, Cao X, Gao J, Zheng Y, Huang S, Han J, Bolli R. PKCepsilon modulates NF-kappaB and AP-1 via mitogen-activated protein kinases in adult rabbit cardiomyocytes [In Process Citation].  Am J Physiol    279:H1679-1689, 2000. ( Full text in PDF file )

  6. Makk LJK, Leesar MA, Joseph A, Prince CP, Wright R. Cardioesophageal reflexes: An invasive human study. Digestive Disease and Sciences 45:2451-2454, 2000.

  7. Murray RD, Shah A, Jasper SE, Goodman A, Deitcher SR, Katz WE, Malouf JE, Stoddard MF, Grimm RA, Klein AL. Transesophageal echocardiography guided enoxaparin antithrombotic strategy for cardioversion of atrial fibrillation: The ACUTE II pilot study. Am Heart J 139:e5, 2000.

  8. Ohman M, Nanas J, Stomel R, Leesar M, Nilsen D, Fraulo B, Shaw L, Pieper K, Lee K. A prospective randomized trial of thrombolysis and counterpulsation to improve cardiogenic shock survival: Preliminary results of the TACTICS trial. Eur Heart J 21:190, 2000.

  9. Ramana KV, Dixit BL, Srivastava S, Balendiran GK, Srivastava SK, Bhatnagar A. Selective recognition of glutathiolated aldehydes by aldose reductase. Biochemistry-US 39:12172-12180, 2000.

  10. Ruef, J., Liu, S.-Q., Bode, C., Tocchi, M., Srivastava, S., Runge, M., Bhatnagar, A. Involvement of aldose reductase in vascular smooth muscle cell growth and lesion formation after arterial injury. Arterio Thromb Vasc Biol 20:1745-1752, 2000.

  11. Shinmura K, Tang XL, Wang Y, Xuan YT, Liu SQ, Takano H, Bhatnagar A, Bolli R. Cyclooxygenase-2 mediates the cardioprotective effects of the late phase of ischemic preconditioning in conscious rabbits [In Process Citation].  Proc Natl Acad Sci U S A.   97:10197-10202, 2000. ( Full text in PDF file )

  12. Singer I, Edmonds H.L. Jr. Tissue Oximetry for the Diagnosis of Neurally Mediated Syncope. Pacing and Clinical Electrophysiology 23:2006-2009, 2000.

  13. Srivastava S, Dixit BL, Cai J, Sharma S, Hurst HE, Bhatnagar A, Srivastava SK. Metabolism of lipid peroxidation product, 4-hydroxynonenal (HNE) in rat erythrocytes: role of aldose reductase. Free Radic Biol Med.   29:642-651., 2000. ( Full text in PDF file )

  14. Stoddard MF. Risk of Thromboembolism in Acute Atrial Fibrillation or Atrial Flutter. Echocardiography J Card 17:393-405, 2000.

  15. Takano H, Tang XL, Bolli R. Differential role of KATP channels in late preconditioning against myocardial stunning and infarction in rabbits.  Am J Physiol    279:H2350-H2359, 2000.( Full text in PDF file )

  16. Takano H, Tang XL, Kodani E, Bolli R. Late preconditioning enhances recovery of myocardial function after infarction in conscious rabbits.  Am J Physiol    279:H2372-H2381, 2000. ( Full text in PDF file )

  17. Teichert A-M, Miller TL, Wang Y, Xie B, Phillips MJ, Marsden PA. In Vivo Expression Profile of an Endothelial Nitric Oxide Synthase Promoter-Reporter Transgene. Am J Physiol 278:H1352-H1361, 2000.

  18. Xuan YT, Tang XL, Qiu Y, Banerjee S, Takano H, Han H, Bolli R. Biphasic response of cardiac NO synthase to ischemic preconditioning in conscious rabbits.  Am J Physiol     279:H2360-H2371, 2000. ( Full text in PDF file )

  19. Bolli R. The Late Phase of Preconditioning. Circ Res.    87:972-983, 2000. ( Full text in PDF file )

Back To Top

2001

  1. Bhat G, Dowling RD. Evaluation of predictors of clinical outcome after partial left ventriculectomy. Ann Thorac Surg 72:91-95, 2001.

  2. Bolli R, Dawn B, Xuan YT. Emerging Role of the JAK-STAT Pathway as a Mechanism of Protection Against Ischemia/Reperfusion Injury.  J Mol Cell Cardiol.   33:1893-1896., 2001. ( Full text in PDF file )

  3. Bolli R. Cardioprotective function of inducible nitric oxide synthase and role of nitric oxide in myocardial ischemia and preconditioning: an overview of a decade of research. J Mol Cell Cardiol.   33:1897-1918., 2001.  ( Full text in PDF file )

  4. Chen L, Hahn H, Wu GY, Chen CH, Liron T, Schechtman D, Cavallaro G, Banci L, Guo YR, Bolli R, Dorn GW, Mochly-Rosen D. Opposing cardioprotective actions and parallel hypertrophic effects of delta PKC and epsilon PKC. Proc Natl Acad Sci U S A. 98:11114-11119, 2001.

  5. Dawn B, Bolli R. Toward a better understanding of the metabolic effects of ischemic preconditioning in humans. J Cardiothorac Vasc Anesth. 15:409-411, 2001.
    Ferns J, Dowling R, Bhat G. Evaluation of a patient with left ventricular assist device dysfunction. Asaio J. 47:696-698, 2001.

  6. Hill M, Takano H, Tang XL, Kodani E, Shirk G, Bolli R. Nitroglycerin induces late preconditioning against myocardial infarction in conscious rabbits despite development of nitrate tolerance. Circulation.   104:694-699., 2001. ( Full text in PDF file )

  7. Kodani E, Bolli R, Tang XL, Auchampach JA. Protection of IB-MECA against myocardial stunning in conscious rabbits is not mediated by the A1 adenosine receptor.  Basic Res Cardiol.   96:487-496., 2001. ( Full text in PDF file )

  8. Kodani E, Shinmura K, Xuan YT, Takano H, Auchampach JA, Tang XL, Bolli R. Cyclooxygenase-2 does not mediate late preconditioning induced by activation of adenosine A1 or A3 receptors.  Am J Physiol Heart Circ Physiol.   281:H959-968., 2001. ( Full text in PDF file )

  9. Pass JM, Gao J, Jones WK, Wead WB, Wu X, Zhang J, Baines CP, Bolli R, Zheng YT, Joshua IG, Ping P. Enhanced PKCbetaII translocation and PKCbetaII-RACK1 interactions in PKCepsilon-induced heart failure: a role for RACK1.  Am J Physiol Heart Circ Physiol.    281:H2500-2510., 2001.( Full text in PDF file )

  10. Srivastava S, Conklin DJ, Liu SQ, Prakash N, Boor PJ, Srivastava SK, Bhatnagar A. Identification of biochemical pathways for the metabolism of oxidized low-density lipoprotein derived aldehyde-4-hydroxy trans-2-nonenal in vascular smooth muscle cells.  Atherosclerosis.    158:339-350., 2001. ( Full text in PDF file )

  11. Srivastava S, Dixit BL, Ramana KV, Chandra A, Chandra D, Zacarias A, Petrash JM, Bhatnagar A, Srivastava SK. Structural and kinetic modifications of aldose reductase by S-nitrosothiols.  Biochem J.   358:111-118., 2001. ( Full text in PDF file )

  12. Xuan YT, Guo Y, Han H, Zhu Y, Bolli R. An essential role of the JAK-STAT pathway in ischemic preconditioning. Proc Natl Acad Sci U S A.   98:9050-9055., 2001. ( Full text in PDF file )

  13. Zacarias A, Bolanowski D, Bhatnagar A. Comparative measurements of multicomponent phospholipid mixtures by electrospray mass spectroscopy: relating ion intensity to concentration. Anal. Biochem 308:152-159, 2001.

  14. Banerjee S, Linder MW, Singer I. False –positive Troponin I in a patient with acute cholecystitis and positive rheumatoid factor assay. Cardiology 95:170-171, 2001.

  15. Bhatnagar A, Ruef J, Liu S, Srivastava S, Srivastava SK. Regulation of vascular smooth muscle cell growth by aldose reductase. Chem Biol Interact.   130-132:627-636., 2001. ( Full text in PDF file )

  16. Dawn B, Xuan YT, Marian M, Flaherty MP, Murphree SS, Smith TL, Bolli R, Jones WK. Cardiac-specific abrogation of NF- kappa B activation in mice by transdominant expression of a mutant I kappa B alpha.  J Mol Cell Cardiol.   33:161-173., 2001.( Full text in PDF file )

  17. Dixit BL, Ramana KV, Chandra D, Jackson EB, Srivastava S, Bhatnagar A, Srivastava SK. Metabolic Regulation of Aldose Reductase Activity by Nitric Oxide Donors. Chem-Biol Interact 130:573-581, 2001.

  18. Guo Y, Bolli R, Bao W, Wu WJ, Black RG, Jr., Murphree SS, Salvatore CA, Jacobson MA, Auchampach JA. Targeted deletion of the A3 adenosine receptor confers resistance to myocardial ischemic injury and does not prevent early preconditioning.  J Mol Cell Cardiol.   33:825-830., 2001. ( Full text in PDF file )

  19. Klein AL, Grimm RA, Murray RD, Apperson-Hansen C, Asinger RW, Black IW, Davidoff R, Erbel R, Halperin JL, Orsinelli DA, Porter TR, Stoddard MF. The ACUTE Steering and Publications Committee for the ACUTE Investigators. Transesophageal Echocardiography Guided Cardioversion of Patients with Atrial Fibrillation. N Engl J Med 344:1411-1420, 2001. 

  20. Leesar MA, Stoddard MF, Dawn B, Jasti VG, Masden R, Bolli R. Delayed preconditioning-mimetic action of nitroglycerin in patients undergoing coronary angioplasty.  Circulation.   103:2935-2941., 2001. ( Full text in PDF file )

  21. Li Q, Bolli R, Qiu Y, Tang XL, Guo Y, French BA. Gene therapy with extracellular superoxide dismutase protects conscious rabbits against myocardial infarction.  Circulation.    103:1893-1898., 2001. ( Full text in PDF file )

  22. Liu SQ, Jin H, Zacarias A, Srivastava S, Bhatnagar A. Binding of pyridine nucleotide coenzymes to the beta-subunit of the voltage-sensitive K+ channel.  J Biol Chem.   276:11812-11820., 2001. ( Full text in PDF file )

  23. Liu SQ, Jin H, Zacarias A, Srivastava S, Bhatnagar A. Binding of pyridine coenzymes to the beta-subunit of the voltage sensitive potassium channels.  Chem Biol Interact.   130-132:955-962., 2001. ( Full text in PDF file )

  24. O’Connell TD, Rokosh DG, Simpson PC. Cloning and Characterization of the Mouse 1C/A-Adrenergic Receptor Gene and Analysis of an 1C Promoter in Cardiac Myocytes: Role of an MCAT Element That Binds TEF-1. Mol Pharm 9:1225-1234, 2001

  25. Pass JM, Zheng Y, Wead WB, Zhang J, Li RC, Bolli R, Ping P. PKCepsilon activation induces dichotomous cardiac phenotypes and modulates PKCepsilon-RACK interactions and RACK expression. Am J Physiol Heart Circ Physiol.    280:H946-955., 2001. ( Full text in PDF file )

  26. Ping P, Zhang J, Pierce WM, Jr., Bolli R. Functional proteomic analysis of protein kinase C epsilon signaling complexes in the normal heart and during cardioprotection.  Circ Res.   88:59-62., 2001. ( Full text in PDF file )

  27. Ramana KV, Dixit BL, Srivastava S, Bhatnagar A, Balendiran GK, Watowich SJ, Petrash JM, Srivastava SK. Characterization of the Glutathione Binding Site of Aldose Reductase. Chem-Biol Interact 130:537-548, 2001.

  28. Rubins HB, Davenport J, Babikian V, Brass LM, Collins D, Wexler L, Wagner S, et al. Reduction in Stroke With Gemfibrozil in Men With Coronary Heart Disease and Low HDL Cholesterol. The Veterans Affairs HDL Intervention Trial (VA-HIT). Circulation 103:2828-2833, 2001

  29. Takano H, Bolli R, Black RG, Jr., Kodani E, Tang XL, Yang Z, Bhattacharya S, Auchampach JA. A(1) or A(3) adenosine receptors induce late preconditioning against infarction in conscious rabbits by different mechanisms.  Circ Res.   88:520-528., 2001. ( Full text in PDF file )

  30. Vondriska TM, Zhang J, Song C, Tang XL, Cao X, Baines CP, Pass JM, Wang S, Bolli R, Ping P. Protein kinase C epsilon-Src modules direct signal transduction in nitric oxide-induced cardioprotection: complex formation as a means for cardioprotective signaling. Circ Res.   88:1306-1313., 2001. ( Full text in PDF file )

  31. Srivastava S, Liu SQ, Conklin DJ, Zacarias A, Srivastava SK, Bhatnagar A. Involvement of aldose reductase in the metabolism of atherogenic aldehydes.  Chem Biol Interact.   130-132:563-571., 2001. ( Full text in PDF file )

Back To Top

2002

  1. Baines CP, Zhang J, Wang GW, Zheng YT, Xiu JX, Cardwell EM, Bolli R, Ping P.Mitochondrial PKCepsilon and MAPK Form Signaling Modules in the Murine Heart: Enhanced Mitochondrial PKCepsilon-MAPK Interactions and Differential MAPK Activation in PKCepsilon-Induced Cardioprotection. Circ Res 90:390-397, 2002 ( Full text in PDF file )

  2. Balafanova Z, Bolli R, Zhang J, Zheng Y, Pass JM, Bhatnagar A, Tang XL, Wang O, Cardwell E, Ping. Nitric oxide induces nitration of PKCepsilon, facilitating PKCepsilon translocation via enhanced PKCepsilon -RACK2 interactions: A novel mechanism of NO-triggered activation of PKCepsilon. J Biol Chem    2002 Apr 26;277(17):15021-7. ( Full text in PDF file )

  3. Bhat G, Dowling RD. Evaluation of predictors of clinical outcome after partial left bentriculectomy. Ann Thorac Surg 72:91-95, 2002. 

  4. Bolli R. Regeneration of the human heart--no chimera? N Engl J Med 2002 Jan 3;346(1):55-6

  5. Chandra D, Jackson EB, Ramana KV, Kelley R, Srivastava SK, Bhatnagar A. Nitric oxide prevents aldose reductase activation and sorbitol accumulation during diabetes. Diabetes 51:3095-3101, 2002.

  6. Chandra D, Ramana KV, Wang LF, Christensen BN, Bhatnagar A, Srivastava SK. Inhibition of fiber cekk globulization and hyperglycemia- induced lens opacification by aminopeptidase inhibitor bestatin. Invest Ophthalmol Vis Sci 43:2285-2292, 2002.

  7. Hoque A, Maaieh M, Longaker RA, Stoddard MF. Exercise echocardiography and thallium-201 single-photon emission computed tomography stress test for 5- and 10-year prognosis of mortality and specific cardiac events. J Am Soc Echocardiogr 15:1326-1334, 2002.

  8. Cross HR, Murphy E, Bolli R, Ping P, Steenbergen C. Expression of activated PKC epsilon protects the ischemic heart, without attenuating ischemic H+ production. J Mol Cell Cardiol 34:361-367, 2002

  9. Dawn B, Takano H, Tang XL, Kodani E, Banerjee S, Rezazadeh A, Qiu Y, Bolli R. Role of Src protein tyrosine kinases in late preconditioning against myocardial infarction. Am J Physiol Heart Circ Physiol 2002 Aug;283(2):H549-H556 ( Full text in PDF file )

  10. Black RG Jr, Guo Y, Ge ZD, Murphree SS, Prabhu SD, Jones WK, Bolli R, Auchampach JA.Gene dosage-dependent effects of cardiac-specific overexpression of the A3 adenosine receptor. Circ Res 91:165-172, 2002 ( Full text in PDF file )

  11. Kodani E, Xuan YT, Shinmura K, Takano H, Tang XL, Bolli R. Delta-opioid receptor-induced late preconditioning is mediated by cyclooxygenase-2 in conscious rabbits. Am J Physiol Heart Circ Physiol. 2002 Nov;283(5):H1943-57. ( Full text in PDF file )

  12. Kodani E, Xuan YT, Takano H, Shinmura K, Tang XL, Bolli R. Role of cyclic guanosine monophosphate in late preconditioning in conscious rabbits. Circulation 2002 Jun 25;105(25):3046-52 ( Full text in PDF file )

  13. Ping P, Song C, Zhang J, Guo Y, Cao X, Li RC, Wu W, Vondriska TM, Pass JM, Tang XL, Pierce WM, Bolli R. Formation of protein kinase C(epsilon)-Lck signaling modules confers cardioprotection. J Clin Invest 109:499-507, 2002. ( Full text in PDF file )

  14. Ramana KV, Chandra D, Srivastava S, Bhatnagar A, Aggarwal BB, Srivastava SK. Aldose reductase mediates mitogenic signaling in vascular smooth muscle cells. J Biol Chem 277:32063-32070, 2002

  15. Shinmura K, XuanYT, Tang XL, Kodani E, Han H, Zhu Y, Bolli R.Inducible Nitric Oxide Synthase Modulates Cyclooxygenase-2 Activity in the Heart of Conscious Rabbits During the Late Phase of Ischemic Preconditioning. Circ Res 90:602-608, 2002 ( Full text in PDF file )

  16. Shinmura K, Bolli R, Liu SQ, Tang XL, Kodani E, Xuan YT, Srivastava S, Bhatnagar A. Aldose reductase is an obligatory mediator of the late phase of ischemic preconditioning. Circ Res. 2002 Aug 9;91(3):240-6   ( Full text in PDF file )

  17. Shinmura K, Nagai M, Tamaki K, Tani M, Bolli R. Cyclooxygenase-2-derived prostacyclin mediates opioid-induced late phase of preconditioning in isolated perfused rat hearts. Am J Physiol 283:H2534-H2543, 2002.

  18. Mitchell RG, Stoddard MF, Ben-Yehuda O, Aggarwal KB, Allenby KS, Trillo RA, Loyd R, Chang CT, Labovitz AJ. Esmolol in acute ischemic syndromes. Am Heart J 144:E9, 2002. 

  19. Garimella S, Longaker RA, Stoddard MF. Safety of transesophageal echocardiography in patients who are obese. J Am Soc Echocardiog 15:1396-1400,2002. 

  20. Hoque A, Maaieh M, Longaker RA, Stoddard MF. Exercise echocardiography and thallium-201 single-photon emission computed tomography stress test for 5- and 10-year prognosis of mortality and specific cardiac events. J Am Soc Echocardiogr 15:1326-1334, 2002. 

  21. Stoddard MF, Longaker RA, Calzada N. Left atrial inflow propagation rate: a new transesophageal echocardiographic index of preload. J Am Soc Echocardiogr 15:1057-1064, 2002. 

  22. Quinones MA, Otto CM, Stoddard M, Waggoner A, Zoghbi WA; Doppler Quantification Task Force of the Nomenclature and Standards Committee of the American Society of Echocardiography. Recommendations for quantification of Doppler echocardiography: a report from the Doppler Quantification Task Force of the Nomenclature and Standards Committee of the American Society of Echocardiography. J Am Soc Echocardiogr 15:167-184, 2002. 

  23. Banerjee S, Yalamanchili VS, Abdul-Baki T, Stoddard MF. Use of atropine to maintain higher heart rate after exercise during treadmill stress echocardiography. J Am Soc Echocardiogr 15:43-45, 2002.

  24. Gallik DM, Singer I, Meissner MD, Molnar J, Somberg JC. Hemodynamic and surface electrocardiographic effects of a new aqueous formulation of intravenous amiodarone. Am J Cardiol 90:964-968, 2002. 

  25. Giudici M, Winston S, Kappler J, Shinn T, Singer I, Scheiner A, Berrier H, Herner M, Sample R. Mapping the coronary sinus and great cardiac vein. Pacing Clin Electrophysiol 25:414-419, 2002.

  26. Srivastava S, Chandrasekar B, Bhatnagar A, Prabhu SD. Lipid peroxidation-derived aldehydes and oxidative stress in the failing heart: role of aldose reductase. Am J Physiol-Heart Circul Physiol 283:H2612-H2619, 2002.

  27. Stoddard MF, Longaker RA, Calzada N. Left atrial inflow propagation rate: A new transesophageal echocardiographic index of preload. J Am Soc Echocardiogr 15:1057-1064, 2002

  28. Tang XL, Takano H, Rizvi A,  Turrens JF, Qiu Y, Wu WJ, Zhang Q, and Bolli R. Oxidant species trigger late preconditioning against myocardial stunning in conscious rabbits Am J Physiol Heart Circ Physiol   282: H281-H291, 2002. ( Full text in PDF file )

  29. Wang Y, Guo Y, Zhang SX, Wu WJ, Wang J, Bao W, Bolli R. Ischemic Preconditioning Upregulates Inducible Nitric Oxide Synthase in Cardiac Myocyte.  J Mol Cell Cardiol.    34:5-15, 2002. ( Full text in PDF file )

  30. Bolli R, Shinmura K, Tang XL, Kodani E, Xuan Y, Guo Y, Dawn B. Discovery of a new function of cyclooxygenase (COX)-2: COX-2 is a cardioprotective protein that alleviates ischemia/reperfusion injury and mediates the late phase of preconditioning. Cardiovasc Res 2002 Aug 15;55(3):506 ( Full text in PDF file )

Back To Top

2003

  1. Stoddard MF, Calzada N, Longaker RA. Left atrial inflow propagation rate derived by transesophageal color M-mode echocardiography is a promising index of preload. Clin Cardiol 26:201-204, 2003.

  2. Stoddard MF, Singh P, Dawn B, Longaker RA. Left atrial thrombus predicts transient ischemic attack in patients with atrial fibrillation. Am Heart J 145:676-682, 2003.

  3. Sasaki N, Murata M, Guo Y, Jo SH, Ohler A, Akao M, O'Rourke B, Xiao RP, Bolli R, Marban E. MCC-134, a single pharmacophore, opens surface ATP-sensitive potassium channels, blocks mitochondrial ATP-sensitive potassium channels, and suppresses preconditioning. Circulation. 2003 Mar 4;107(8):1183-8. (Full text in PDF file )

  4. Leesar MA, Abdul-Baki T, Akkus NI, Sharma A, Kannan T, Bolli R. Use of fractional flow reserve versus stress perfusion scintigraphy after unstable angina. Effect on duration of hospitalization, cost, procedural characteristics, and clinical outcome. J Am Coll Cardiol. 2003 Apr 2;41(7):1115-21. (Full text in PDF file )

  5. Bolli R, Dawn B, Xuan YT.  Role of the JAK-STAT Pathway in Protection Against Myocardial Ischemia/Reperfusion Injury. Trends Cardiovasc Med. 2003 Feb;13(2):72-9. ( Full text in PDF file )

  6. Tang XL, Kodani E, Takano H, Hill M, Shinmura K, Vondriska TM, Ping P, Bolli R.  Protein tyrosine kinase signaling is necessary for NO donor-induced late preconditioning against myocardial stunning. Am J Physiol Heart Circ Physiol.  2003 Apr;284(4):H1441-8. ( Full text in PDF file )

  7. Baines CP, Song CX, Zheng YT, Wang GW, Zhang J, Wang OL, Guo Y, Bolli R, Cardwell EM, Ping P. Protein Kinase C{epsilon} Interacts With and Inhibits the Permeability Transition Pore in Cardiac Mitochondria. Circ Res.  2003 May 2;92(8):873-80. Epub 2003 Mar 27. (Full text in PDF file )

  8. Li Q, Guo Y, Xuan YT, Lowenstein CJ, Stevenson SC, Prabhu SD, Wu WJ, Zhu Y, Bolli R. Gene therapy with inducible nitric oxide synthase protects against myocardial infarction via a cyclooxygenase-2-dependent mechanism. Circ Res. 2003 Apr 18;92(7):741-8. (Full text in PDF file )

  9. Xuan YT, Guo Y, Zhu Y, Han H, Langenbach R, Dawn B, Bolli R. Mechanism of cyclooxygenase-2 upregulation in late preconditioning. J Mol Cell Cardiol. 2003 May;35(5):525-37.  (Full text in PDF file )

  10. Shinmura K, Kodani E, Xuan YT, Dawn B, Tang XL, Bolli R. Effect of aspirin on late preconditioning against myocardial stunning in conscious rabbits. J Am Coll Cardiol. 2003 Apr 2;41(7):1183-94.  (Full text in PDF file )

  11. Bhatnagar A. Surviving hypoxia: the importance of rafts, anchors, and fluidity. Circ Res 92:821-823, 2003.

  12. Tsakadze NL, Srivastava S, Awe SO, Adeagbo AS, Bhatnagar A, D'Souza SE. Acrolein-Induced Vasomotor Responses of Rat Aorta. Am J Physiol Heart Circ Physiol 2003 May 1 [Epub ahead of print]

  13. Ramana KV, Chandra D, Srivastava S, Bhatnagar A, Srivastava SK. Nitric oxide regulates the polyol pathway of glucose metabolism in vascular smooth muscle cells. FASEB J 17:417-425, 2003.

  14. Bhatnagar A, Kumar R, Tipparaju SM, Liu SQ. Differential pyridine nucleotide coenzyme binding to the beta-subunit of the voltage-sensitive K+ channel: a mechanism for redox regulation of excitability? Chem Biol Interact 143-144:613-620, 2003.

  15. Bolli R. The role of sodium-hydrogen ion exchange in patients undergoing coronary artery bypass grafting. J Card Surg 2003 Jan-Feb;18 Suppl 1:21-6 

  16. Chandra D, Ramana KV, Friedrich B, Srivastava S, Bhatnagar A, Srivastava SK. Role of aldose reductase in TNF-alpha-induced apoptosis of vascular endothelial cells. Chem Biol Interact 143-144:605-612, 2003.

  17. Liu SQ, Yin J, Bhatnagar A. Protein kinase C-dependent phosphorylation of the beta-subunit of the voltage-sensitive potassium channels (Kvbeta2). Chem Biol Interact 143-144:597-604, 2003.

  18. Ramana KV, Chandra D, Srivastava S, Bhatnagar A, Srivastava SK. Aldose reductase mediates the mitogenic signals of cytokines. Chem Biol Interact 143-144:587-596, 2003.

  19. Srivastava SK, Ramana KV, Chandra D, Srivastava S, Bhatnagar A. Regulation of aldose reductase and the polyol pathway activity by nitric oxide. Chem Biol Interact 143-144:333-340, 2003.

  20. Varma T, Liu SQ, West M, Thongboonkerd V, Ruvolo PP, May WS, Bhatnagar A. Protein kinase C-dependent phosphorylation and mitochondrial translocation of aldose reductase. FEBS Lett 534:175-179, 2003.

  21. Ramana KV, Friedrich B, Bhatnagar A, Srivastava SK. Aldose reductase mediates cytotoxic signals of hyperglycemia and TNF-alpha in human lens epithelial cells. FASEB J  17:315-317, 2003.

  22. Leesar MA, Stoddard MF, Xuan YT, Tang XL, Bolli R. Nonelectrocardiographic evidence that both ischemic preconditioning and adenosine preconditioning exist in humans. J Am Coll Cardiol. 2003 Aug 6;42(3):437-45. (Full text in PDF file ).

  23. Bhat G, Costea A.Reversibility of medically unresponsive pulmonary hypertension with nesiritide in a cardiac transplant recipient. ASAIO J. 2003 Sep-Oct;49(5):608-10.

  24. Dawn B, Talley JD, Prince CR, Hoque A, Morris GT, Xenopoulos NP, Stoddard MF.  Two-dimensional and Doppler transesophageal echocardiographic delineation and flow characterization of anomalous coronary arteries in adults. J Am Soc Echocardiogr. 2003 Dec;16(12):1274-86.

  25. Prabhu SD, Wang G, Luo J, Gu Y, Ping P, Chandrasekar B.  Beta-adrenergic receptor blockade modulates Bcl-X(S) expression and reduces apoptosis in failing myocardium. J Mol Cell Cardiol. 2003 May;35(5):483-93.

Back To Top

2004

  1. Bapat A, Recto MR, Bhat G. Transcatheter closure of a patent foramen ovale in an adult with hypoxemia after cardiac transplantation. Tex Heart Inst J. 2004;31:175-7.

  2. Tang XL, Xuan YT, Zhu Y, Shirk G, Bolli R.Nicorandil induces late preconditioning against myocardial infarction in conscious rabbits. Am J Physiol Heart Circ Physiol. 2004 Apr;286(4):H1273-80.(Full text in PDF file).

  3. Bhat G, Daley K, Dugan M, Larson G. Preoperative evaluation for bariatric surgery using transesophageal dobutamine stress echocardiography. Obes Surg. 2004;14:948-51.

  4. Jneid H, Bolli R. Inotrope use at separation from cardiopulmonary bypass and the role of prebypass TEE. J Cardiothorac Vasc Anesth. 2004;18:401-3.

  5. Wongpraparut N, Yalamachili V, Leesar MA. Novel implication of combined stent crushing and intravascular ultrasound for dislodged stents. J Invasive Cardiol. 2004;16:445-6.

  6. Kucia M, Dawn B, Hunt G, Guo Y, Wysoczynski M, Majka M, Ratajczak J, Rezzoug F, Ildstad ST, Bolli R, Ratajczak MZ. Cells expressing early cardiac markers reside in the bone marrow and are mobilized into the peripheral blood after myocardial infarction. Circ Res. 2004;95:1191-9.

  7. Srivastava S, Spite M, Trent JO, West MB, Ahmed Y, Bhatnagar A. Aldose reductase-catalyzed reduction of aldehyde phospholipids. J Biol Chem. 2004;279:53395-406.

  8. Shinmura K, Nagai M, Tamaki K, Bolli R. Gender and aging do not impair opioid-induced late preconditioning in rats. Basic Res Cardiol. 2004 Jan;99(1):46-55.

  9. Hensley K, Benaksas EJ, Bolli R, Comp P, Grammas P, Hamdheydari L, Mou S, Pye QN, Stoddard MF, Wallis G, Williamson KS, West M, Wechter WJ, Floyd RA. New perspectives on vitamin E: gamma-tocopherol and carboxyelthylhydroxychroman metabolites in biology and medicine. Free Radic Biol Med. 2004 Jan 1;36(1):1-15.(Full text in PDF file).

  10. Dawn B, Guo Y, Rezazadeh A, Wang OL, Stein AB, Hunt G, Varma J, Xuan YT, Wu WJ, Tan W, Zhu X, Bolli R. Tumor necrosis factor-alpha does not modulate ischemia/reperfusion injury in naive myocardium but is essential for the development of late preconditioning. J Mol Cell Cardiol. 2004 Jul;37(1):51-61. (Full text in PDF file).

  11. Leesar MA, Masden R, Jasti V. Physiological and intravascular ultrasound assessment of an ambiguous left main coronary artery stenosis. Catheter Cardiovasc Interv. 2004;62:349-57.

  12. Wang Y, Kodani E, Wang J, Zhang SX, Takano H, Tang XL, Bolli R. Cardioprotection during the final stage of the late phase of ischemic preconditioning is mediated by neuronal NO synthase in concert with cyclooxygenase-2. Circ Res. 2004 Jul 9;95(1):84-91. (Full text in PDF file).

  13. Bolli R, Becker L, Gross G, Mentzer R, Jr., Balshaw D, Lathrop DA. Myocardial protection at a crossroads: the need for translation into clinical therapy. Circ Res. 2004;95:125-34.

  14. Anversa P, Sussman MA, Bolli R. Molecular genetic advances in cardiovascular medicine: focus on the myocyte. Circulation. 2004;109:2832-8.

  15. Pasnoori VR, Leesar MA. Use of aminophylline in the treatment of severe symptomatic bradycardia resistant to atropine. Cardiol Rev. 2004;12:65-8.

  16. Guo Y, Stein AB, Wu WJ, Tan W, Zhu X, Li QH, Dawn B, Motterlini R, Bolli R. Administration of a CO-Releasing Molecule at the Time of Reperfusion Reduces Infarct Size In Vivo. Am J Physiol Heart Circ Physiol. 2004 May;286(5):H1649-53. (Full text in PDF file).

  17. Stein AB, Tang XL, Guo Y, Xuan YT, Dawn B, Bolli R. Delayed Adaptation of the Heart to Stress. Late Preconditioning. Stroke. 2004 Sep 30 [Epub ahead of print] (Full text in PDF file)

  18. Tang XL, Stein AB, Shirk G, Bolli R. Hypercholesterolemia blunts NO donor-induced late preconditioning against myocardial infarction in conscious rabbits. Basic Res Cardiol. 2004 Sep;99(6):395-403.(Full text in PDF file).

  19. Zhang J, Ping P, Wang GW, Lu M, Pantaleon D, Tang XL, Bolli R, Vondriska TM. Bmx, a member of the Tec family of nonreceptor tyrosine kinases, is a novel participant in pharmacological cardioprotection. Am J Physiol Heart Circ Physiol. 2004;287:H2364-6.

  20. Jasti V, Ivan E, Yalamanchili V, Wongpraparut N, Leesar MA. Correlations between fractional flow reserve and intravascular ultrasound in patients with an ambiguous left main coronary artery stenosis. Circulation. 2004;110:2831-6.

  21. Costea A, Bhat G. Hyperhomocysteinemia and deep vein thrombosis in orthotopic heart transplantation: a case report. Am J Hematol. 2004;77:161-3.

  22. Siddiqui TS, Stoddard MF. Safety of dobutamine stress transesophageal echocardiography in obese patients for evaluation of potential ischemic heart disease. Echocardiography. 2004;21:603-8.

  23. Dawn B, Xuan YT, Guo Y, Rezazadeh A, Stein AB, Hunt G, Wu WJ, Tan W, Bolli R. IL-6 plays an obligatory role in late preconditioning via JAK-STAT signaling and upregulation of iNOS and COX-2. Cardiovasc Res. 2004 Oct 1;64(1):61-71.(Full text in PDF file).

  24. Shinmura K, Tamaki K, Sato T, Ishida H, Bolli R. Prostacyclin Attenuates Oxidative Damage of Myocytes by Opening Mitochondrial ATP-Sensitive K+ Channels via the EP3 Receptor. Am J Physiol Heart Circ Physiol. 2004. in press

Back To Top

2005

 

  1. Prabhu SD. Post-infarction ventricular remodeling: an array of molecular events. J Mol Cell Cardiol. 2005;38:547-50.

  2. Dawn B, Bolli R. HO-1 induction by HIF-1: a new mechanism for delayed cardioprotection? Am J Physiol Heart Circ Physiol. 2005;289:H522-4.

  3. Shinmura K, Tamaki K, Bolli R. Short-term caloric restriction improves ischemic tolerance independent of opening of ATP-sensitive K+ channels in both young and aged hearts. J Mol Cell Cardiol. 2005;39:285-96.

  4. Bolli R, Abdel-Latif A. No pain, no gain: the useful function of angina. Circulation. 2005;112:3541-3.

  5. Tipparaju SM, Saxena N, Liu SQ, Kumar R, Bhatnagar A. Differential regulation of voltage-gated K+ channels by oxidized and reduced pyridine nucleotide coenzymes. Am J Physiol Cell Physiol. 2005;288:C366-76.

  6. Dawn B, Bolli R. Bone marrow cells for cardiac regeneration: the quest for the protagonist continues. Cardiovasc Res. 2005;65:293-5.

  7. Dawn B, Stein AB, Urbanek K, Rota M, Whang B, Rastaldo R, Torella D, Tang XL, Rezazadeh A, Kajstura J, Leri A, Hunt G, Varma J, Prabhu SD, Anversa P, Bolli R. Cardiac stem cells delivered intravascularly traverse the vessel barrier, regenerate infarcted myocardium, and improve cardiac function. Proc Natl Acad Sci U S A. 2005;102:3766-71.

  8. Jones SP, Bolli R. The ubiquitous role of nitric oxide in cardioprotection. J Mol Cell Cardiol. 2006;40:16-23.

  9. Luo J, Xuan YT, Gu Y, Prabhu SD. Prolonged oxidative stress inverts the cardiac force-frequency relation: role of altered calcium handling and myofilament calcium responsiveness. J Mol Cell Cardiol. 2006;40:64-75.

  10. Stein AB, Guo Y, Tan W, Wu WJ, Zhu X, Li Q, Luo C, Dawn B, Johnson TR, Motterlini R, Bolli R. Administration of a CO-releasing molecule induces late preconditioning against myocardial infarction. J Mol Cell Cardiol. 2005;38:127-34.

  11. Martindale JJ, Wall JA, Martinez-Longoria DM, Aryal P, Rockman HA, Guo Y, Bolli R, Glembotski CC. Overexpression of mitogen-activated protein kinase kinase 6 in the heart improves functional recovery from ischemia in vitro and protects against myocardial infarction in vivo. J Biol Chem. 2005;280:669-76. Kucia M, Reca R, Jala VR, Dawn B, Ratajczak J, Ratajczak MZ. Bone marrow as a home of heterogenous populations of nonhematopoietic stem cells. Leukemia. 2005;19:1118-27.

  12. Guo Y, Stein AB, Wu WJ, Zhu X, Tan W, Li Q, Bolli R. Late preconditioning induced by NO donors, adenosine A1 receptor agonists, and delta1-opioid receptor agonists is mediated by iNOS. Am J Physiol Heart Circ Physiol. 2005;289:H2251-7.

  13. Urbanek K, Torella D, Sheikh F, De Angelis A, Nurzynska D, Silvestri F, Beltrami CA, Bussani R, Beltrami AP, Quaini F, Bolli R, Leri A, Kajstura J, Anversa P. Myocardial regeneration by activation of multipotent cardiac stem cells in ischemic heart failure. Proc Natl Acad Sci U S A. 2005;102:8692-7.

  14. Srivastava S, Tammali R, Chandra D, Greer DA, Ramana KV, Bhatnagar A, Srivastava SK. Regulation of lens aldose reductase activity by nitric oxide. Exp Eye Res. 2005;81:664-72.

  15. Dawn B, Varma J, Singh P, Longaker RA, Stoddard MF. Cardiovascular death in patients with atrial fibrillation is better predicted by left atrial thrombus and spontaneous echocardiographic contrast as compared with clinical parameters. J Am Soc Echocardiogr. 2005;18:199-205.

  16. Ramana KV, Friedrich B, Tammali R, West MB, Bhatnagar A, Srivastava SK. Requirement of aldose reductase for the hyperglycemic activation of protein kinase C and formation of diacylglycerol in vascular smooth muscle cells. Diabetes. 2005;54:818-29.

  17. Dawn B, Paliwal VS, Raza ST, Mastali K, Longaker RA, Stoddard MF. Left ventricular outflow tract obstruction provoked during dobutamine stress echocardiography predicts future chest pain, syncope, and near syncope. Am Heart J. 2005;149:908-16.

  18. Jneid H, Leessar M, Bolli R. Cardiac Preconditioning during Percutaneous Coronary Interventions. Cardiovasc Drugs Ther. 2005;19:211-7.

  19. Shinmura K, Tamaki K, Sato T, Ishida H, Bolli R. Prostacyclin attenuates oxidative damage of myocytes by opening mitochondrial ATP-sensitive K+ channels via the EP3 receptor. Am J Physiol Heart Circ Physiol. 2005;288:H2093-101.

  20. Srivastava SK, Ramana KV, Bhatnagar A. Role of aldose reductase and oxidative damage in diabetes and the consequent potential for therapeutic options. Endocr Rev. 2005;26:380-92.

  21. Jneid H, Chandra M, Alshaher M, Hornung CA, Tang XL, Leesar M, Bolli R. Delayed preconditioning-mimetic actions of nitroglycerin in patients undergoing exercise tolerance tests. Circulation. 2005;111:2565-71.

  22. Syed FM, Hahn HS, Odley A, Guo Y, Vallejo JG, Lynch RA, Mann DL, Bolli R, Dorn GW, 2nd. Proapoptotic effects of caspase-1/interleukin-converting enzyme dominate in myocardial ischemia. Circ Res. 2005;96:1103-9.

  23. Anversa P, Rota M, Urbanek K, Hosoda T, Sonnenblick EH, Leri A, Kajstura J, Bolli R. Myocardial aging A stem cell problem. Basic Res Cardiol. 2005;100:482-93.

  24. Bolli R. Foreword-focused issue on cardiac repair by stem cells. Basic Res Cardiol. 2005;100:469-70.

  25. Dawn B, Bolli R. Adult bone marrow-derived cells: Regenerative potential, plasticity, and tissue commitment. Basic Res Cardiol. 2005;100:494-503.

  26. Leri A, Kajstura J, Quaini F, Urbanek K, Bolli R, Anversa P. Repair of the damaged heart. Kidney Int. 2005;68:1962.

  27. Bolli R, Jneid H, Dawn B. Bone marrow cell-mediated cardiac regeneration a veritable revolution. J Am Coll Cardiol. 2005;46:1659-61.

  28. Dawn B, Bolli R. Cardiac progenitor cells: the revolution continues. Circ Res. 2005;97:1080-2.

  29. Tang XL, Takano H, Xuan YT, Sato H, Kodani E, Dawn B, Zhu Y, Shirk G, Wu WJ, Bolli R. Hypercholesterolemia abrogates late preconditioning via a tetrahydrobiopterin-dependent mechanism in conscious rabbits. Circulation. 2005;112:2149-56.

  30. Shinmura K, Bolli R. The risk for myocardial infarction with cyclooxygenase-2 inhibitors. Ann Intern Med. 2005;143:617; author reply 617-8.

  31. Prabhu SD. Allopurinol and heart failure: a new use for an old drug? J Mol Cell Cardiol. 2005;39:407-9.

  32. Li Q, Guo Y, Tan W, Stein AB, Dawn B, Wu WJ, Zhu X, Lu X, Xu X, Siddiqui T, Tiwari S, Bolli R. Gene Therapy with Inducible Nitric Oxide Synthase Provides Long-Term Protection against Myocardial Infarction without Adverse Functional Consequences. Am J Physiol Heart Circ Physiol. 2005.

  33. Xuan YT, Guo Y, Zhu Y, Wang OL, Rokosh G, Messing RO, Bolli R. Role of the protein kinase C-epsilon-Raf-1-MEK-1/2-p44/42 MAPK signaling cascade in the activation of signal transducers and activators of transcription 1 and 3 and induction of cyclooxygenase-2 after ischemic preconditioning. Circulation. 2005;112:1971-8.

Back To Top

2006

 

  1. Luo J, Xuan YT, Gu Y, Prabhu SD.  Prolonged oxidative stress inverts the cardiac force-frequency relation: role of altered calcium handling and myofilament calcium responsiveness. J Mol Cell Cardiol. 2006 Jan;40(1):64-75. Epub 2005 Nov 8.  PMID: 16288776 [PubMed - indexed for MEDLINE]

  2. Dawn B, Guo Y, Rezazadeh A, Huang Y, Stein AB, Hunt G, Tiwari S, Varma J, Gu Y, Prabhu SD, Kajstura J, Anversa P, Ildstad ST, Bolli R.  Postinfarct cytokine therapy regenerates cardiac tissue and improves left ventricular function. Circ Res. 2006 Apr 28;98(8):1098-105. Epub 2006 Mar 23. PMID: 16556872 [PubMed - indexed for MEDLINE]

  3. Srivastava S, Ramana KV, Tammali R, Srivastava SK, Bhatnagar A.   Contribution of aldose reductase to diabetic hyperproliferation of vascular smooth muscle cells.  Diabetes. 2006 Apr;55(4):901-10.  PMID: 16567509 [PubMed - indexed for MEDLINE]

  4. Kaiserova K, Srivastava S, Hoetker JD, Awe SO, Tang XL, Cai J, Bhatnagar A.  Redox activation of aldose reductase in the ischemic heart. J Biol Chem. 2006 Jun 2;281(22):15110-20. Epub 2006 Mar 27.  PMID: 16567803 [PubMed - indexed for MEDLINE]

  5. West MB, Hill BG, Xuan YT, Bhatnagar A.  Protein glutathiolation by nitric oxide: an intracellular mechanism regulating redox protein modification. FASEB J. 2006 Aug;20(10):1715-7. Epub 2006 Jun 29.  PMID: 16809435 [PubMed - indexed for MEDLINE]

  6. Zuba-Surma EK, Abdel-Latif A, Case J, Tiwari S, Hunt G, Kucia M, Vincent RJ, Ranjan S, Ratajczak MZ, Srour EF, Bolli R, Dawn B.  Sca-1 expression is associated with decreased cardiomyogenic differentiation potential of skeletal muscle-derived adult primitive cells. J Mol Cell Cardiol. 2006 Oct;41(4):650-60. Epub 2006 Aug 30. PMID: 16938308 [PubMed - indexed for MEDLINE]

  7. Tang XL, Sato H, Tiwari S, Dawn B, Bi Q, Li Q, Shirk G, Bolli R.  Cardioprotection by postconditioning in conscious rats is limited to coronary occlusions <45 min. Am J Physiol Heart Circ Physiol. 2006 Nov;291(5):H2308-17. Epub 2006 Jun 30. PMID: 16815986 [PubMed - indexed for MEDLINE]

  8. Conklin DJ, Bhatnagar A, Cowley HR, Johnson GH, Wiechmann RJ, Sayre LM, Trent MB, Boor PJ.  Acrolein generation stimulates hypercontraction in isolated human blood vessels.  Toxicol Appl Pharmacol. 2006 Dec 15;217(3):277-88. Epub 2006 Sep 29. PMID: 17095030 [PubMed - indexed for MEDLINE]

  9. Awe SO, Adeagbo AS, D'Souza SE, Bhatnagar A, Conklin DJ.  Acrolein induces vasodilatation of rodent mesenteric bed via an EDHF-dependent mechanism. Toxicol Appl Pharmacol. 2006 Dec 15;217(3):266-76. Epub 2006 Aug 26.  PMID: 17069868 [PubMed - indexed for MEDLINE]

  10. Anversa P, Kajstura J, Leri A, and Bolli R. Life and death of cardiac stem cells: a paradigm shift in cardiac biology. Circulation 113: 1451-1463, 2006.Awe SO, Adeagbo AS, D'Souza SE, Bhatnagar A, and Conklin DJ. Acrolein induces vasodilatation of rodent mesenteric bed via an EDHF-dependent mechanism. Toxicol Appl Pharmacol 217: 266-276, 2006.

  11. Banchs JE, Dawn B, Abdel-Latif A, Qureshi A, Agrawal N, Bouvette M, and Stoddard MF. Acquired aortic cusp fusion after chronic left ventricular assist device support. J Am Soc Echocardiogr 19: 1401 e1401-1403, 2006.

  12. Bhatnagar A. Environmental cardiology: studying mechanistic links between pollution and heart disease. Circ Res 99: 692-705, 2006.

  13. Conklin DJ, Bhatnagar A, Cowley HR, Johnson GH, Wiechmann RJ, Sayre LM, Trent MB, and Boor PJ. Acrolein generation stimulates hypercontraction in isolated human blood vessels. Toxicol Appl Pharmacol 217: 277-288, 2006.

  14. Dawn B and Bolli R. Increasing evidence that estrogen is an important modulator of bone marrow-mediated cardiac repair after acute infarction. Circulation 114: 2203-2205, 2006.

  15. Dawn B, Hasnie AM, Calzada N, Longaker RA, and Stoddard MF. Transesophageal echocardiography impacts management and evaluation of patients with stroke, transient ischemic attack, or peripheral embolism. Echocardiography 23: 202-207, 2006.

  16. Jones SP and Bolli R. The ubiquitous role of nitric oxide in cardioprotection. J Mol Cell Cardiol 40: 16-23, 2006.

  17. Kajstura J, Bolli R, Sonnenblick EH, Anversa P, and Leri A. Cause of death: suicide. J Mol Cell Cardiol 40: 425-437, 2006.

  18. Kajstura J, Leri A, Bolli R, and Anversa P. Endothelial progenitor cells: neovascularization or more? J Mol Cell Cardiol 40: 1-8, 2006.

  19. Kajstura J, Rota M, Urbanek K, Hosoda T, Bearzi C, Anversa P, Bolli R, and Leri A. The telomere-telomerase axis and the heart. Antioxid Redox Signal 8: 2125-2141, 2006.

  20. Li Q, Guo Y, Tan W, Stein AB, Dawn B, Wu WJ, Zhu X, Lu X, Xu X, Siddiqui T, Tiwari S, and Bolli R. Gene therapy with iNOS provides long-term protection against myocardial infarction without adverse functional consequences. Am J Physiol Heart Circ Physiol 290: H584-589, 2006.

  21. Satran A, Dawn B, and Leesar MA. Congenital ostial left main coronary artery stenosis associated with a bicuspid aortic valve in a young woman. J Invasive Cardiol 18: E114-116, 2006.

  22. Siddiqui TS, Dawn B, and Stoddard MF. Hypotension during dobutamine stress transesophageal echocardiography: relationship with provoked left ventricular obstruction. J Am Soc Echocardiogr 19: 1144-1149, 2006.

  23. Urbanek K, Cesselli D, Rota M, Nascimbene A, De Angelis A, Hosoda T, Bearzi C, Boni A, Bolli R, Kajstura J, Anversa P, and Leri A. Stem cell niches in the adult mouse heart. Proc Natl Acad Sci U S A 103: 9226-9231, 2006.

  24. Wang J, Song Y, Elsherif L, Song Z, Zhou G, Prabhu SD, Saari JT, and Cai L. Cardiac metallothionein induction plays the major role in the prevention of diabetic cardiomyopathy by zinc supplementation. Circulation 113: 544-554, 2006.

  25. West MB, Hill BG, Xuan YT, and Bhatnagar A. Protein glutathiolation by nitric oxide: an intracellular mechanism regulating redox protein modification. Faseb J 20: 1715-1717, 2006.

  26. Zuba-Surma EK, Abdel-Latif A, Case J, Tiwari S, Hunt G, Kucia M, Vincent RJ, Ranjan S, Ratajczak MZ, Srour EF, Bolli R, and Dawn B. Sca-1 expression is associated with decreased cardiomyogenic differentiation potential of skeletal muscle-derived adult primitive cells. J Mol Cell Cardiol 41: 650-660, 2006.

Back To Top

2007

 

  1. Stein AB, Tiwari S, Thomas P, Hunt G, Levent C, Stoddard MF, Tang XL, Bolli R, Dawn B.  Effects of anesthesia on echocardiographic assessment of left ventricular structure and function in rats. Basic Res Cardiol. 2007 Jan;102(1):28-41. Epub 2006 Oct 2. PMID: 17006633 [PubMed - in process]

  2. Abdel-Latif A, Bolli R, Tleyjeh IM, Montori VM, Perin EC, Hornung CA, Zuba-Surma EK, Al-Mallah M, Dawn B. Adult bone marrow-derived cells for cardiac repair: a systematic review of the literature and meta-analysis. Arch Intern Med. 2007; 167: 989-997.

  3. Dawn B and Bolli R. Bone marrow for cardiac repair: the importance of characterizing the phenotype and function of injected cells. Eur Heart J 28: 651-652, 2007.

  4. Hill BG and Bhatnagar A. Role of glutathiolation in preservation, restoration and regulation of protein function. IUBMB Life 59: 21-26, 2007.

  5. Leesar MA, Jneid H, Tang XL, and Bolli R. Pretreatment with intracoronary enalaprilat protects human myocardium during percutaneous coronary angioplasty. J Am Coll Cardiol 49: 1607-1610, 2007.

  6. Prabhu SD. Altered left ventricular-arterial coupling precedes pump dysfunction in early heart failure. Heart Vessels 22: 170-177, 2007.

  7. Alshaher M, El-Mallakh R, Dawn B, Siddiqui T, Longaker RA, and Stoddard MF. Cardiac manifestations of exhaustive exercise in nonathletic adults: does cardiac fatigue occur? Echocardiography 24: 237-242, 2007.

  8. Spite M, Baba SP, Ahmed Y, Barski OA, Nijhawan K, Petrash JM, Bhatnagar A, and Srivastava S. Substrate specificity and catalytic efficiency of aldo-keto reductases with phospholipid aldehydes. Biochem J 405: 95-105, 2007.

  9. Srivastava S, Chandrasekar B, Gu Y, Luo J, Hamid T, Hill BG, and Prabhu SD. Downregulation of CuZn-superoxide dismutase contributes to beta-adrenergic receptor-mediated oxidative stress in the heart. Cardiovasc Res 74: 445-455, 2007.

  10. Stein AB, Bolli R, Guo Y, Wang OL, Tan W, Wu WJ, Zhu X, Zhu Y, and Xuan YT. The late phase of ischemic preconditioning induces a prosurvival genetic program that results in marked attenuation of apoptosis. J Mol Cell Cardiol 42: 1075-1085, 2007.

  11. Tipparaju SM, Liu SQ, Barski OA, and Bhatnagar A. NADPH binding to beta-subunit regulates inactivation of voltage-gated K(+) channels. Biochem Biophys Res Commun 359: 269-276, 2007.

  12. Travis AR, Giridharan GA, Pantalos GM, Dowling RD, Prabhu SD, Slaughter MS, Sobieski M, Undar A, Farrar DJ, and Koenig SC. Vascular pulsatility in patients with a pulsatile- or continuous-flow ventricular assist device. J Thorac Cardiovasc Surg 133: 517-524, 2007.

  13. Siddiqui TS, Elghoul Z, Reza ST, and Leesar MA. Renal hemodynamics: theory and practical tips. Catheter Cardiovasc Interv 69: 894-901, 2007.

  14. Amunom I, Stephens LJ, Tamasi V, Cai J, Pierce WM, Jr., Conklin DJ, Bhatnagar A, Srivastava S, Martin MV, Guengerich FP, and Prough RA. Cytochromes P450 catalyze oxidation of alpha,beta-unsaturated aldehydes. Arch Biochem Biophys, 2007.

  15. Anversa P, Leri A, Rota M, Hosoda T, Bearzi C, Urbanek K, Kajstura J, and Bolli R. Concise review: stem cells, myocardial regeneration, and methodological artifacts. Stem Cells 25: 589-601, 2007.

  16. Bolli R. Preconditioning: a paradigm shift in the biology of myocardial ischemia. Am J Physiol Heart Circ Physiol 292: H19-27, 2007.

  17. Bolli R, Li QH, Tang XL, Guo Y, Xuan YT, Rokosh G, and Dawn B. The late phase of preconditioning and its natural clinical application-gene therapy. Heart Fail Rev, 2007.

  18. Ramana KV, Tammali R, Reddy AB, Bhatnagar A, and Srivastava SK. Aldose Reductase -Regulated TNF-{alpha} Production Is Essential For High Glucose-Induced Vascular Smooth Muscle Cell Growth. Endocrinology, 2007.

  19. Shah A, Alshaher M, Dawn B, Siddiqui T, Longaker RA, Stoddard MF, and El-Mallakh R. Exercise tolerance is reduced in bipolar illness. J Affect Disord, 2007.

  20. Amunom I, Stephens LJ, Tanasi V, Cai J, Pierce WJ, Conklin DJ, Bhatnagar A, Srivastava S, Martin MV, Guengerich FP, Prough R.A. Cytochromes P450 catalyze oxidation of α,β-unsaturated aldehydes.  Arch Biochem Biophy 2007; 464:187-196.

  21. Bearzi C, Rota M, Hosoda T, Tillmanns J, Nascimbene A, DeAngelis A, Yasuzawa-Amano S, Trofimova L, Siggins RW, Lecapitaine N, Cascapera S, Beltrami A, D’Alessandro DA, Quaini Z, Urbanek K, Michler R, Bolli R, Kajstura J, Leri A, Anversa P.  Human cardiac stem cells.  Proc Nat Acad Sci 2007; 104: 14068-73.

  22. Benjamin I, Guo Y, Srinivasan S, Boudina S, Taylor R, Rajasekaran N, Gottlieb R, Wawrousek E, Abel D, Bolli R.  CRYAB and HSPB2 deficiency alters cardiac  metabolism and paradoxically confers protection against myocardial ischemia in mice. Am J Physiol 2007; 293(5):H3201-H3209. Epub Sep 14.

  23. Flaherty M, Guo Y, Tiwari S, Rezazadeh A, Hunt G, Tang XL, Bolli R, Dawn B.  The role of TNF-α receptors p55 and p75 in acute myocardial ischemia/reperfusion injury and late preconditioning.  J Mol Cell Cardiol  (In Press)

  24. Hu X, Dai S, Wu WJ, Tan W, Zhu X, Mu J, Guo Y, Bolli R, Rokosh DG. 2007, SDF-1a confers protection against Myocardial Ischemia/Reperfusion Injury: Role of the Cardiac SDF-1a–CXCR4 Axis, Circulation 2007; 116:654-663.

  25. Kajstura J, Urbanek K, Rota M, Bearzi C, Hosoda T, Bolli R, Anversa P, Leri A.  Cardiac stem cells and myocardial disease.  J Mol Cell Cardiol  (In Press).

  26. Koenig SC, Giridharan GA, Ewert D, Schroeder M, Ionan C, Slaughter MS, Sobieski MA Pantalos GM, Dowling RD, Prabhu SD. Human, bovine and porcine systemic vascular input impedance are not equivalent: Implications for device testing and xenotransplantion in heart failure. 2007 (submitted).

  27. Li Q, Guo Y, Tan W, Ou Q, Wu WJ, Sturza D, Dawn B, Hunt G, Cui C, Bolli R. Cardioprotection afforded by Inducible Nitric Oxide Synthase Gene Therapy Is Mediated by Cyclooxygenase-2 via a Nuclear Factor-{kappa}B Dependent Pathway. Circulation. 2007; 116(14):1577-1584. Epub 2007 Sep 4.

  28. Makkar A, Siddiqui TS, Stoddard MF, Lewis PK, Dawn B. Impact of valvular calcification on the diagnostic accuracy of transesophageal echocardiography for the  detection of congenital aortic valve malformation. Echocardiography 2007; 24(7):745-749.

  29. Leesar MA, Jneid H, Tang XL, Bolli R. Pretreatment with intracoronary enalaprilat protects human myocardium during percutaneous coronary angioplasty. J Am Coll Cardiol 2007; 49:1607-1610.

  30. Li Q, Guo Y, Tan W, Ou Q, Wu W, Sturza D, Dawn B, Hunt G, Cui C, Bolli R.  The cardioprotection afforded by inducible nitric oxide synthase gene therapy is mediated by COX-2 via an NF-κB –dependent pathway. Circulation 2007; 116:1577-1584.

  31. Luo J, Hill BG, Gu Y, Cai J, Srivastava S, Bhatnagar A, Prabhu SD. Mechanisms of acrolein-induced myocardial dysfunction: Implications for   environmental and endogenous aldehyde exposure. Am J Physiol Heart Circ Physiol 2007; 293:H3673–H3684.

  32. Rota M, Kajstura J, Hosoda T, Bearzi C, Vitale S, Esposito G, Iaffaldano G, Padin-Iruegas ME, Gonzalez A, Rizzi R, Small N, Muraski J, Alvarez R, Chen X, Urbanek K, Bolli R, Houser SR, Leri A, Sussman MA, Anversa P.  Bone marrow cells adopt the cardiomyogenic fate in vivo.  Proc Nat Acad Sci 2007; 104: 17783-17788.

  33. Sato H, Bolli R, Rokosh G, Bi Q, Dai S, Shirk G, Tang XL.  The cardioprotection of the late phase of ischemic preconditioning is enhanced by postconditioning via a COX-2 mediated mechanism in conscious rats.  Am J Physiol 2007; 293:H2557-2564.

  34. Shah A, Alshaher M, Dawn B,  Siddiqui T,     Longaker RA, Stoddard MF, El-Mallakh R.  Exercise tolerance is reduced in bipolar illness. Journal of Affective Disorders. 2007; 104(1-3):191-195.

  35. Shinmura K, Tamaki K, Saito K, Nakano Y, Tobe T, Bolli R.  Cardioprotective effects of short-term caloric restriction are mediated by adiponectin via activation of AMP-activated protein kinase.  Circulation 2007; 116:2809-2817.

  36. Shinmura K, Nagai M, Tamaki K, Bolli R.  Loss of  ischemic preconditioning in ovariectomized rat hearts: possible involvement of impaired PKCε phosphorylation.  Cardiovasc Res (In Press).

  37. Shinmura K, Tamaki K, Bolli R.  Impact of 6-month caloric restriction on myocardial ischemic tolerance in middle-aged rats.  (Submitted)

  38. Song Y, Du Y, Prabhu SD, Epstein PN. Diabetic cardiomyopathy in OVE26 mice shows mitochondrial ROS production and divergence between in vivo and  in vitro contractility. Rev Diabet Stud 2007; 4:159-68.

  39. Spite M, Baba SP, Ahmed Y, Barski OA, Nijhawan K, Petrash JM, Bhatnagar A, Srivastava S. Substrate specificity and catalytic efficiency of aldo-keto  reductases with phospholipid aldehydes. Biochem J  2007; 405(1), 95-105.

  40. Srivastava S, Chandrasekar B, Gu Y, Luo J, Hamid T, Hill BG, Prabhu SD. Downregulation of CuZn-superoxide dismutase: A novel mechanism for β-adrenergic receptor-mediated oxidative stress in the heart. Cardiovasc Res  2007; 74:445-455.

  41. Srivastava S, D’Souza SE, Sen U, States JC In utero arsenic exposure induces early onset of atherogenesis in apo E -/- mice. Reproduction Toxicology 2007; 23: 449-456.

  42. Stein AB, Tiwari S, Thomas P, Hunt G, Levent C, Stoddard MF, Tang XL, Bolli R, Dawn B. Effects of anesthesia on echocardiographic assessment of left ventricular structure and function in rats. Basic Res Cardiol 2007; 102:28-41.

  43. Stein AB, Bolli R, Guo Y, Wang OL, Tan W, Wu WJ, Zhu XP, Zhu Y, Xuan YT.  The late phase of ischemic preconditioning induces a prosurvival genetic program that results in marked attenuation of apoptosis.  J Mol Cell Cardiol. 2007; 42:1075-1085.

  44. Tipparaju SM, Liu S, Barski OA, Bhatnagar A. NADPH Binding to b-Subunit Regulates Inactivation of Voltage-Gated K+ Channels. BBRC 2007; 359:269-276.

  45. Xuan YT, Guo Y, Zhu Y, Wang OL, Rokosh G, Bolli R.  Endothelial nitric oxide synthase plays an obligatory role in the late phase of ischemic preconditioning by activating the protein kinase C{epsilon}-p44/42 mitogen-activated protein kinase-pSer-signal transducers and activators of transcription1/3 pathway.  Circulation 2007; 116:535-544.

 

  Back To Top

2008

 

  1.  Abdel-Latif A, Zuba-Surma EK, Case J, Tiwari S, Hunt G, Ranjan S, Vincent RJ, Srour EF, Bolli R, Dawn B. TGF-β1 enhances cardiomyogenic differentiation potential of skeletal muscle-derived adult primitive cells. Basic Res Cardiol 2008 [Epub ahead of print].

  2. Abdel-Latif A, Bolli R, Zuba-Surma EK, Tleyjeh IM, Hornung CA, Dawn B. G-CSF therapy for cardiac repair after acute myocardial infarction: A systematic review and meta-analysis of randomized controlled trials. Am Heart J 2008; June 24 [Epub ahead of  print].

  3. Alshaher M,  etal. Efficacy and safety of pyridoxal 5'-phosphate (MC-1) in high-risk patients undergoing coronary artery bypass graft surgery: the MEND-CABG II randomized clinical trial. MEND-CABG II Investigators:  JAMA. 2008; 299(15):1777-87.

  4. Arteel GA, Guo L, Schlierf T, Beier JI, Kaiser JP, Chen TS, Liu M, Conklin DJ, Miller HL, von Montfort C,  States JC.  Subhepatotoxic exposure to arsenic enhances lipopolysaccharide-induced liver injury in mice.  Tox Appl. Pharm 2008; 226(2):128-139.

  5. Bartoli CR, Wilson GC, Giridharan GA, Slaughter MS, Sobieski MA, Prabhu SD, Spence PA, Koenig SC. A novel subcutaneous counterpulsation device provides cardiac hemodynamic support over a range of physiological conditions. 2008 (submitted).

  6. Deschênes I, Armoundas AA, Jones SP, Tomaselli GF.  Post-transcriptional gene silencing of KChIP2 in cardiac myocytes suggests a structural and developmental link between Ito and Na channel. J Mol Cell Cardiol, 2008.  (In Press)

  7. Flaherty MP, Abdel-Latif A, Li QH, Hunt G, Ranjan S, Ou Q, Tang XL, Johnson RK, Bolli R, Dawn B. Noncanonical Wnt11 signaling is sufficient to induce cardiomyogenic differentiation in unfractionated bone marrow mononuclear cells. Circulation 2008; 117:2241-2252.

  8. Gonzalez A, Rota M, Nurzynska D, Misao Y, Tillmanns J, Ojaimi C, Padin-Iruegas M, Muller P, Esposito G, Bearzi C, Vitale S, Dawn B, SanganalMath SK, Baker M, Hintze TH, Bolli R, Urbanek K, Hosoda T, Anversa  P, Kajstura J, Leri A. Activation of cardiac progenitor  cells reverses the failing heart senescent phenotype and  prolongs lifespan. Circ Res 2008; 102:597-606.

  9. Greer JJM, Duranski MR, Gebregzlabher H, Watson LJ, Jones SP, Lefer DJ.  Sodium nitrite administration does not attenuate mortality and morbidity in congestive heart failure.  Am J Physiol. 2008. (in revision).

  10. Guo Y, Li Q, Wu W, Tan W, Zhu X, Mu J, Bolli R. Endothelial nitric oxide synthase is not necessary for the early phase of ischemic preconditioning in the mouse. J Mol Cell Cardiol 2008; 44: 496-501.

  11. Hamid T, Gu Y, Ortines R, Bhattacharya C, Wang GW, Xuan YT, Prabhu SD. TNF receptors 1 and 2 induce divergent inflammatory and remodeling responses in the failing heart: implications for the results of anti-TNF trials. 2008 (submitted).

  12. Hill BG, Haberzettl P, Srivastava S, Ahmed Y, Bhatnagar  A.  Unsaturated lipid peroxidation-derived aldehydes activate autophagy in vascular smooth muscle cells. Biochem J 2008; 410:525-534.

  13. Huang Y, Ratajczak M, Reca R, Xu H, Tanner M, Rezzoug F, Hussain L, Fugier-Vivier I, Bolli R, Ildstad S. Flt3 expression discriminates HSC subpopulations with differing engraftment-potential: identifying the most potent combination. Transplantation  2008; 85: 1175-1184.

  14. Jones SP, Zachara NE, Ngoh GA, Hill BG, Teshima Y, Bhatnagar A, Hart GW, Marbán E.  Cardioprotection by N-acetylglucosamine linkage to cellular proteins. Circulation 2008; 117: 1172-1182.

  15. Kaiserova K, Tang XL, Srivastava S, Bhatnagar A.  Role of nitric oxide in regulating aldose reductase activation  in the ischemic heart.  J  Biol. Chem 2008; 238: 9101- 9112.

  16. Koenig SC, Litwak KN, Giridharan GA, Pantalos GM, Dowling RD, Prabhu SD, Slaughter MS, Sobieski MA, Spence PA. Acute hemodynamic efficacy and histopathology of a 32-ml subcutaneous counterpulsation device in a calf model of diminished cardiac function. ASAIO J 2008 (in press).

 

 

Back To Top

 

Document Actions
« November 2009 »
November
MoTuWeThFrSaSu
1
2345678
9101112131415
16171819202122
23242526272829
30